Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2012 Healthcare Conference


CAMBRIDGE, Mass., June 13, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will participate in a fireside chat at the Wells Fargo Securities 2012 Healthcare Conference on June 20, 2012 at 1:10 p.m. ET at the InterContinental Hotel, Boston.

The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.



            

Mot-clé


Coordonnées